Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chloroquine for Glioblastoma
NCT04772846Phase 2Unknown
- Sponsor
- Egyptian Medical Syndicate
- Start
- Mar 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chloroquine in glioblastoma (GBM), sponsored by Egyptian Medical Syndicate. Status: unknown.
02
Drugs
chloroquine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04772846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772846.